Skip to content

Recent News

Recent News

BriaCell Presents Clinical Findings at 2020 American Society of Clinical Oncology (ASCO) Meeting
May 29, 2020

Preliminary safety and efficacy data is being presented on May 29 at 9:00 a.m. ET ...

Recent News

BriaCell Files Patent Application for Novel Immune Therapies for Multiple Disease Indications
May 20, 2020

BERKELEY, Calif., and VANCOUVER, British Columbia, May 20, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Recent News

BriaCell Announces Presentation and Abstract Publication at 2020 American Society of Clinical Oncology (ASCO) Meeting
May 14, 2020

• New data and pathological findings on BriaCell’s lead candidate, Bria-IMT™, to be Highlighted at ...

Recent News

BriaCell Continues Business and Clinical Operations During COVID-19 Pandemic
May 12, 2020

• Phase I/IIa clinical study of BriaCell’s lead candidate, Bria-IMT™, for breast cancer treatment, with ...

Recent News

BriaCell Files Patent Application for Novel Therapeutics for Cancer
April 27, 2020

BERKELEY, Calif., and VANCOUVER, British Columbia, April 27, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Recent News

BriaCell Files New Provisional Patent Application for Antibody-Based Treatment of Infectious Diseases
April 21, 2020

BERKELEY, Calif., and VANCOUVER, British Columbia, April 21, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Recent News

BriaCell Files Coronavirus Immunotherapy Patent
April 14, 2020

BERKELEY, Calif., and VANCOUVER, British Columbia, April 14, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Recent News

BriaCell to Present Clinical Data at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting May 29
March 31, 2020

BERKELEY, Calif., and VANCOUVER, British Columbia, March 31, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Recent News

BriaCell Continues Clinical Operations Amidst COVID-19 Pandemic
March 26, 2020

• Phase I/IIa clinical study of BriaCell’s lead candidate, Bria-IMT™, with Incyte Corporation’s immune checkpoint ...

Recent News

BriaCell to Present Clinical and Immune Activity at AACR Annual Meeting
February 26, 2020

• Clinical and immune activity of BriaCell’s lead candidate, Bria-IMT™, alone or in combination with ...